Month: January 2021

Judge Dismisses Zantac Claims on Federal Preemption

In two recent rulings, U.S. District Court Judge Robin L Rosenberg dismissed a host of claims against Zantac defendants based on federal pre-emption. In short, preemption is a doctrine that can shield drug manufacturers from liability in certain cases where they follow the FDA requirements for an approved drug or medication.

Allergan’s Game of Hide & Seek with the FDA

According to complaints filed by plaintiff’s attorneys, Allergan’s misconduct includes using a loophole in the FDAs reporting requirements to hide instances of serious injuries associated with its Biocell textured breast implants. More on that below. Background on Cancer Linked to Allergan Biocell Textured Breast Implants Allergan has been accused of failing to warn patients and …

Allergan’s Game of Hide & Seek with the FDA Read More »

ParaGard MDL Created in Northern District of Georgia

In a much-anticipated decision, the Judicial Panel on Multidistrict Litigation (JPML) ruled on December 16, 2020 to centralize ParaGard IUD claims against Teva Pharmaceuticals in the Northern District of Georgia under Judge Leigh Martin May. The parties to the litigation have been going back and forth for months arguing about which district court is best …

ParaGard MDL Created in Northern District of Georgia Read More »